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Abstract
Background: The diagnostic accuracy of the Patient Health Questionnaire-9 (PHQ-9) for assessment of depression
in elderly persons in primary care settings in the United States has not been previously addressed. Thus, the
purpose of this study was to evaluate the test performance of the PHQ-9 for detecting major and minor
depression in elderly patients in primary care.
Methods: A prospective study of diagnostic accuracy was conducted in two primary care, university-based clinics
in the Pacific Northwest of the United States. Seventy-one patients aged 65 years or older participated; all
completed the PHQ-9 and the 15-item Geriatric Depression Scale (GDS) and underwent the Structured Clinical
Interview for Depression (SCID). Sensitivity, specificity, area under the receiver operating characteristic (ROC) curve,
and likelihood ratios (LRs) were calculated for the PHQ-9, the PHQ-2, and the 15-item GDS for major depression
alone and the combination of major plus minor depression.
Results: Two thirds of participants were female, with a mean age of 78 and two chronic health conditions. Twelve
percent met SCID criteria for major depression and 13% minor depression. The PHQ-9 had an area under the curve
(AUC) of 0.87 (95% confidence interval [CI], 0.74-1.00) for major depression, while the PHQ-2 and the 15-item GDS
each had an AUC of 0.81 (95% CI for PHQ-2, 0.64-0.98, and for 15-item GDS, 0.70-0.91; P = 0.551). For major and
minor depression combined, the AUC for the PHQ-9 was 0.85 (95% CI, 0.73-0.96), for the PHQ-2, 0.80 (95% CI, 0.68-
0.93), and for the 15-item GDS, 0.71 (95% CI, 0.55-0.87; P = 0.187).
Conclusions: Based on AUC values, the PHQ-9 performs comparably to the PHQ-2 and the 15-item GDS in
identifying depression among primary care elderly.
Background
The incidence of major depression in the general elderly
population is approximately 15% per year and doubles
after age 70 [1]. The prevalence of depression is higher
in medical settings than in the community. Depression
is associated with an increased risk of mortality [2],
healthcare utilization [3], functional decline [4-6], and
poorer quality of life [7,8]. Depression is however, quite
responsive to treatment, and antidepressants are as
effective for older adults as for younger individuals [1].
Care management has been shown to improve outcomes
for elderly who are depressed and treated in primary
care settings [9]. Thus, detection of depression among
older adults in primary care is important, as it can be
linked to effective treatment. Additionally, because most
older adults seek care for their mental health issues in
primary care [10], screening in primary care with refer-
ral to a mental health specialist for diagnostic evaluation
of depressive symptoms is neither efficient nor practical
in most instances.
To date, late life depression has been under-recog-
nized and inadequately treated [11-13]. A fundamental
challenge for the primary care provider is recognition of
depression in the elder where depression symptoms and
comorbid medical illness symptoms such as insomnia or
anorexia overlap [14,15]. This situation is further com-
plicated by frequent underreporting of depressive symp-
toms by older adults [12]. A brief screening tool that
accurately identifies depression among elderly patients
would make the identification of depression in primary
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care more straightforward, and improvements in identi-
fication and treatment of depression in elders might
lead to improved function, survival, and quality of life.
Thus, our study objective was to assess the diagnostic
performance of the Patient Health Questionnaire-9
(PHQ-9) [16], a promising depression scale that has
been validated with younger populations, and compare
its performance to an established depression screening
instrument, the 15-item Geriatric Depression Scale
(GDS) [17], among elderly persons receiving health care
in primary care settings. The PHQ-9 is the first self-
report questionnaire designed for use in primary care
that reflects the Diagnostic and Statistical Manual of
Mental Disorders, fourth edition (DSM-IV) diagnostic
criteria for depression, and so (through examining the
pattern and number of items endorsed) can be used as a
diagnostic tool for major and minor depression [16]. By
contrast, other self-report instruments, including the
GDS, do not map to the DSM depression diagnostic cri-
teria and so cannot be used for depression diagnosis
(only screening) [10], meaning that additional evaluation
to establish a depression diagnosis must be conducted
following a positive screen. While the PHQ-9 has been
shown to be useful in general populations [16,18],
including outpatient clinic settings in a variety of coun-
tries [19,20] and sensitive to change in the elderly [21],
to our knowledge, its screening characteristics (sensitiv-
ity and specificity) had not been validated with elderly
in a primary care setting in the United States. If a
screening instrument’s summary score (obtained
through summing individual items scores) correlated
strongly with gold-standard depression diagnosis
obtained via in-person diagnostic interviews, this would
be attractive, as it would make depression detection in
primary care much more straightforward. A validation
study examining this question is important, as the PHQ
is being administered to adults of all ages, including the
elderly, as part of national surveillance efforts to esti-
mate the prevalence of mental health disorders in the
United States [22]. We located only one study that
focused specifically on the validity of the PHQ-9 in
chronically ill elderly in primary care; this study was
conducted in the Netherlands and focused on elders
with diabetics and chronic obstructive pulmonary dis-
ease without known depression enrolled in a rando-
mized trial of a nurse-led, psychological intervention
[23]. We hypothesized that, because the PHQ-9 items
map directly to DSM-IV criteria for depression, the
PHQ-9 would have test performance characteristics at
least comparable to the GDS but perhaps less ease of
use (due to its more complex response format). We
were interested in minor as well as major depression,
because minor depression is more prevalent in primary
care than major depression, is associated with adverse
effects on functioning and may increase the risk of sub-
sequent major depression in older primary care patients
[24,25], increases health care use and costs [24], and
may be responsive to treatment [26-28]. Because brief
screening tools may be preferable for use in primary
care settings, we also examined the sensitivity and speci-
ficity of the PHQ-2, an abbreviated version of the PHQ-




The study was conducted from November 2006 through
August 2007 in two primary care clinics affiliated with
the University of Washington, in Seattle, Washington,
USA. These clinics were chosen because they provide
primary care for elders and because clinic administrators
and providers were supportive of the project.
Study sample and procedures
Participants were consecutive established patients aged
65 or older presenting to the clinics for care. Those for
whom the study procedures were not feasible due to
severe dementia, unstable medical condition, or non-
English fluency, were excluded. After informed consent
was obtained, the PHQ-9 and 15-item GDS were admi-
nistered to each participant by a research assistant. A
geriatric psychiatrist or gerontologic psychiatric nurse
practitioner trained in SCID administration, blinded to
the results of the depression screening tests, conducted
a diagnostic interview for depression, the Structured
Clinical Interview for Depression (SCID). The SCID is
considered the criterion standard for DSM-IV depres-
sion diagnosis in clinical research [29]. Information on
demographic characteristics (age, gender, race) and
chronic conditions was obtained from a questionnaire
completed by the participant at the time of enrollment.
All instruments were administered on the same day in
the context of a routine clinic appointment. To avoid
ordering effects, the order of administration of screening
instruments and the SCID was varied in random fash-
ion. The institutional review board at the University of
Washington approved all procedures.
Depression instruments
The PHQ-9 is a self-administered, nine-item question-
naire specific to depression that is available free to end
users [16]. It was developed as a self-report version of
the Primary Care Evaluation of Mental Disorders
(PRIME-MD). It has several other features that make it
attractive for use with older adults in primary care set-
tings, including being substantially shorter than most
other depression screening measures; having been ori-
ginally developed and tested for use with medical
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patients, who are likely (as are elderly) to have high
rates of physical symptoms consistent with either
chronic medical illness or depression; having excellent
test-retest reliability, excellent criterion [16] and con-
struct validity [18], and responsiveness [21,30], or the
capacity of an instrument to detect meaningful change
over time [31].
Each of the nine items of the PHQ-9 is scored as 0
(not at all), 1 (several days), 2 (more than half the days),
or 3 (nearly every day). As a screening tool, summing
the 9 items, (score range 0-27 with 0 indicating no
depressive symptoms and 27 indicating all symptoms
occurring nearly daily), a score of ≥10 has been shown
to have an 88% sensitivity and 88% specificity for major
depression in a general medical population [18].
As a diagnostic tool, major depression is diagnosed if
≥5 of the 9 symptoms elicited have been present at least
more than half the days in the past two weeks AND one
of these symptoms is either depressed mood or anhedo-
nia [18]. Minor depression is diagnosed if 2-4 symptoms
have been present at least more than half the days in
the past two weeks AND one of the symptoms is either
depressed mood or anhedonia [18].
Depression severity can also be assessed with the
PHQ-9 [16]. Kroenke et al suggested cutpoints to iden-
tify minimal (0-4), mild (5-9), moderate (10-14), moder-
ately severe (15-19), and severe (≥20) depression [18].
These cutpoints have some empiric support, as demon-
strated by a strong association between increasing PHQ-
9 scores and worse scores on functional status (SF-20)
measures, especially for scales most strongly correlated
with depression [18].
The PHQ-2 is an abbreviated version (i.e., the first
two items) of the PHQ-9 that inquires about depressed
mood and anhedonia; it has been studied to a lesser
extent than the PHQ-9 as a depression screening tool
[32-34]. In studies of younger adults in primary care
and obstetrics-gynecology settings, scores of ≥3 have a
sensitivity of 83% and a specificity of 92% for major
depression [33].
The 15-item GDS is the most commonly used, geria-
tric specific depression screen and thus represents the
current “usual care” standard for geriatric depression
screening [17]. Its brevity and dichotomized (yes, no)
response format offer some ease of use advantages. In a
study of persons 60 years or older from primary care
practices, scores of >5 had a sensitivity of 92% and a
specificity of 81% for major depression [17].
Published cutpoints for minor depression are not
available for the three instruments for purposes of
screening. However, the PHQ-9 can be used as a diag-
nostic tool for minor depression, since the items map
directly to DSM minor depression criteria.
Statistical analysis
Our analysis was conducted in three stages. First,
descriptive statistics were calculated to characterize the
sociodemographic and health characteristics of our sam-
ple. Next, sensitivity, specificity, and likelihood ratios
(LRs) for detecting major depression for each of the
three instruments (i.e., including the PHQ-2) were cal-
culated over a range of cutpoints. Ninety-five percent
confidence intervals (95% CI) were calculated for sensi-
tivity and specificity using an online clinical calculator,
available at http://statpages.org/ctab2x2.html. Third,
receiver operating characteristic (ROC) analyses were
conducted. ROC analyses combine instrument sensitivity
and specificity into one measure (referred to as area
under the curve, or AUC) for all possible cutpoints.
AUC values range from ≤0.5 (no discriminatory ability)
to 1.0 (perfect discrimination). An AUC of 0.84 implies
that there is an 84% likelihood that a randomly selected
person with depression will have a higher PHQ-9 score
than a randomly selected non-depressed person. The
AUC was measured to permit comparison of the diag-
nostic value of each instrument for detecting major
depression, for the study group overall and by gender,
ethnicity, age, and burden of comorbidity. A global non-
parametric test for comparison of the 3 AUCs was cal-
culated [35]. Lastly, we calculated sensitivity, specificity,
LRs, and AUCs with depression broadened to include
minor depression. Statistical analyses were performed




A total of 502 unique, established patients were seen in
the clinics during the study period. Of these, 122 were
not approached due either to being non-fluent in Eng-
lish (N = 64) or having severe dementia (N = 58). Of
the 380 remaining, 227 met the age criterion and so
were approached about the study by clinic staff. Of
these, 121 were willing to speak with the research assis-
tant about the study, and 71 agreed to participate.
Baseline characteristics of participants
The 71 participants had a mean age of 78 years; nearly
two-thirds were female, a third were non-white, and
over three-quarters had a high school education (Table
1). They reported having two chronic medical condi-
tions, on average, with hypertension, arthritis, and dia-
betes being the most common (reported by 63%, 49%,
and 24%, respectively). About a quarter had a PHQ-9
score of 10 or greater, and one-fifth had a PHQ-2 score
of three or greater. About half had a GDS score greater
than five. The SCID was positive for major depression
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in 12% and for minor depression in 13%. Thirty percent
needed help to complete the demographics question-
naire, 30% needed help to complete the GDS, and 37%
needed help to complete the PHQ-9. Assistance was
usually in the form of oral administration of the mea-
sures due to poor eyesight or difficulty using a pen. The
yes/no response option format of the GDS was not
clearly easier for participants to use than the four option
response format of the PHQ-9. Participants took about
five minutes to complete the PHQ-9, and about 25-50%
longer to complete the GDS, on average.
Relative performance of depression screening
instruments for major depression
The sensitivity and specificity of the screening measures
were calculated using the SCID as the criterion standard
for major and minor depression diagnosis. Using pub-
lished, standard major depression cutpoints for these
tests, seven of the eight (63%) majorly depressed partici-
pants were correctly classified with the PHQ-9 (cutpoint
≥ 10) and the PHQ-2 (cutpoint ≥ 3), while 100% were
correctly classified with the GDS (cutpoint > 5) (Table
2). At these published cutpoints, the specificity was
higher for the two PHQ measures (PHQ-9, 82%; PHQ-
2, 85%) compared to the 15-item GDS, with a specificity
of 58%. The LR positive represents how much the odds
of having depression increase when a test is positive. At
the standard cutpoints, the two PHQ measures had LR
positives of about four, – i.e., a positive screen is four
times more likely to be seen in someone with major
depression than in someone without – while the 15-
item GDS had a LR positive of 2.4, – i.e., a positive
screen is 2.4 times more likely to be seen in someone
with major depression than in someone without the
condition.
Table 3 reports results from the ROC analysis, which
gives a global assessment of the discriminatory power of
each instrument. Overall, the AUC for the PHQ-9 was
comparable to the AUC for the PHQ-2 and the 15-item
GDS (0.87 for PHQ-9 vs. 0.81 for both the PHQ-2 and
the 15-item GDS, P = 0.551).
As shown in Table 3, the AUC for the PHQ-9 and 15-
item GDS was similar for men and women, whereas for
the PHQ-2, the AUC was lower for women. This same
pattern of AUCs for the three instruments held for
white and non-white participants. The PHQ-9 appeared
somewhat more discriminatory for those under the age
of 80 years, whereas the PHQ-2 and the 15-item GDS
discriminated comparably for these subgroups. The
PHQ-9 and PHQ-2 AUC values were highest for partici-
pants with less than three comorbidities (0.93 and 0.92,
respectively), whereas the AUC for the 15-item GDS
was similar regardless of comorbidity burden.
Relative performance of depression screening
instruments using broadened definition of depression
When the broadened definition of depression was used
(i.e., including minor and major depression), the sensi-
tivity of all three measures worsened as compared with
their case detection for major depression alone (Table
4). For example, at the PHQ-9 cutpoint of ≥10, the sen-
sitivity using the broadened definition was 59% as
opposed to 63%; at the PHQ-2 cutpoint of ≥3, the sensi-
tivity was 53% as opposed to 63%. For the 15-item GDS,
at the cutpoint of >5, the sensitivity was 81% as opposed
to 100%. AUC values using the broadened definition of
depression were: PHQ-9 = 0.85 (95% CI, 0.73-0.96);
PHQ-2 = 0.80 (95% CI, 0.68-0.93); and 15-item GDS =
0.71 (95% CI, 0.55-0.87); P = 0.187 for comparison of
AUCs for the three instruments.
Discussion
This study demonstrated that, used as a screening
instrument, the PHQ-9 performed comparably to the
PHQ-2 and the 15-item GDS for the purposes of major
depression detection in elderly individuals in primary
care. Broadening the definition of depression to include
minor along with major depression did not improve
Table 1 Demographic and health characteristics of
participants at enrollment (N = 71)
Characteristic
Age, years, mean ± SD* 78 ± 7
Female, % 62
Non-white, % 32
High school graduate, % 82
Chronic medical conditions
Mean ± SD 2.3 ± 1.5
Median (interquartile range) 2 (2)
Three or more chronic medical conditions, % 42
Patient Health Questionnaire-9 (PHQ-9)
Score, mean ± SD 5.9 ± 6.1
Score ≥10, %† 23 (16/71)
Patient Health Questionnaire-2 (PHQ-2)
Score, mean ± SD 1.2 ± 1.6
Score ≥3, %‡ 20 (14/71)
15-Item Geriatric Depression Scale (GDS)
Score, mean ± SD 5.8 ± 1.8
Score >5, %§ 48 (33/69)
Structured Clinical Interview for Depression (SCID)
Major depression, % 12 (8/69)
Minor depression, % 13 (9/69)
* SD = standard deviation.
† Scores of 10 or greater on the PHQ-9 suggest likely major depression in
general medical populations [18].
‡ Scores of 3 or greater on the PHQ-2 suggest possible depression in adults in
primary care and obstetrics-gynecology settings [33].
§ Scores greater than 5 on the 15-item GDS suggest major depression in older
adults in primary care [17].
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performance of any of the three screening instruments.
Self-administration of the PHQ-9 did not result in sub-
stantially greater need for assistance, compared to the
GDS, among our study sample. The PHQ-9 performed
comparably regardless of gender or race and somewhat
better for younger elders and for those with less chronic
illness. The prevalence of major depression in our sam-
ple was 12%, comparable to that found in other studies
of elderly across a range of health care settings [36], and
the prevalence of minor depression was 13%.
This study was motivated by a desire to address the
challenge of depression recognition by non-psychiatric
physicians, and in particular, recognition of depression
in the elderly where depression symptoms and symp-
toms of comorbid medical illness overlap [13-15]. The
utility of the PHQ-9 for detection of depression in other
populations has been previously documented
[16,18,37-46]; however, to our knowledge, ours is the
first study to examine its screening characteristics for
both major and any (major or minor) depression with
Table 2 Sensitivity and specificity of depression screening instruments for diagnosing major depression at various
cutpoints*




+ Likelihood Ratio - Likelihood Ratio
PHQ-9 Cutpoint
≥8 88 75 3.6 0.16
(56-98) (71-77)
≥9 88 80 4.4 0.16
(56-98) (76-82)
≥10 63 82 3.5 0.46
(33-86) (78-85)
≥11 63 84 3.8 0.45
(33-85) (80-87)
≥12 63 84 3.8 0.45
(33-85) (80-87)
PHQ-2 Cutpoint
≥1 88 61 2.2 0.21
(55-98) (56-62)
≥2 75 67 2.3 0.37
(43-93) (63-70)
≥3 63 85 4.2 0.44
(33-85) (81-88)
≥4 38 93 5.7 0.67
(15-62) (91-97)
≥5 38 98 22.9 0.64
(16-48) (96-100)
15-item GDS Cutpoint
≥5 100 15 1.2 0.00
(73-100) (11-15)
≥6 100 58 2.4 0.00
(70-100) (54-59)
≥7 75 77 3.2 0.33
(43-93) (72-79)
≥8 25 87 1.9 0.86
(7-54) (84-91)
≥9 13 93 1.9 0.94
(2-37) (92-97)
* Cutpoints are specific sum scores that distinguish between individuals with and without the disorder. Bolded cutpoints indicate the optimum balance between
sensitivity and specificity, while italicized cutpoints are those that are typically cited in the literature as being those that optimize sensitivity and specificity for
the detection of major depression for each respective instrument when applied to the general population.
† CI = confidence interval.
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an exclusively older adult study sample in a primary
care clinic setting in the United States. With an AUC
for major depression in our study of 0.87, the perfor-
mance of the PHQ-9 in identifying major depression
was somewhat worse than has been demonstrated for
general medical populations, where the AUC was 0.95
[18]. In the only other published study that we were
able to locate that focused specifically on the validity of
the PHQ-9 in an elderly sample, the AUC for major
depression was 0.92 [23]. It is of interest that, despite
substantial differences between our two study samples
(i.e., northern European vs. United States origin;
enrolled in a randomized controlled trial vs. consecu-
tively enrolled from a primary care clinic; excluded if
carried a prior diagnosis of depression or other psychia-
tric disorder vs. depression and/or other psychiatric dis-
order other than severe dementia did not preclude
participation) our results for major depression detection
through use of the PHQ-9 are quite comparable. Taken
together, they provide evidence in support of the instru-
ment’s validity as a screening instrument for elders with
chronic illness, including those who carry a depression
diagnosis or other psychiatric disorder.
Of note, the low specificity (i.e., 58%) of the 15-item
GDS for major depression at the standard cutpoint (i.e.,
>5) may limit its use with older persons similar to those in
our study, because many would need follow-up evaluation
to receive a specific depression diagnosis. By contrast,
both the PHQ-9 and PHQ-2 have better sensitivity and
specificity at the standard major depression cutpoints;
however, compared to the 15-item GDS, both risk missing
cases because of their lower sensitivity at those cutpoints.
It is of interest that the optimal cutpoints for detec-
tion of major depression for the instruments evaluated
in this study varied from previously published cutpoints
for general medical populations. Specifically, a PHQ-9
cutpoint of ≥9, a PHQ-2 cutpoint of ≥2, and a GDS cut-
point of ≥7 offered the best combination of sensitivity
and specificity for our study participants. The need to
modify cutpoints to achieve the best balance between
sensitivity and specificity for elderly populations has
been observed in other studies [23,36]. More research in
this area appears warranted.
Even with modification of cutpoints, our results
demonstrate that the PHQ-2 performs less well for detec-
tion of major depression among primary care elderly as
compared to younger adults, where sensitivity and speci-
ficity have been reported to be 83% and 92% respectively
[33]. Our finding is, however, consistent with the one
study that examined the utility of the PHQ-2 for detect-
ing major depression in elderly primary care patients and
found a sensitivity of only 79% and specificity of 58%
with a cutpoint of 1 or greater [36].
In contrast to other studies, wherein broadening the defi-
nition of depression to include depression of lesser severity
and dysthymia improved the sensitivity of depression
screening instruments [23,36], our study demonstrated that
sensitivity was not improved through this maneuver. Sensi-
tivity in our study was determined to have decreased as the
result of an increase in false negatives that occurred when
the definition of depression was broadened (data not
shown). However, AUC values derived using our broa-
dened definition remained comparable to those derived
using the narrower (major depression only) definition and
still in the acceptable range of discrimination.
This study was limited by several factors. First, we did
not assess the percentage of patients already diagnosed
with depression or the percentage on antidepressants.
Second, our sample was in essence a convenience sam-
ple, rather than a nationally representative sample of
elders receiving care in primary care settings. Addition-
ally, our sample size was smaller than anticipated, due
in part to substantial numbers of clinic patients being
ineligible to participate because of language barriers
(non-fluent in English) and cognitive dysfunction, and in
part to a relatively low acceptance of study participation.
The small sample size likely contributed to the small
number (i.e., 8) of cases of major depression in the
study, and this small number in turn limits interpreta-
tion of the statistical comparisons of the screening
Table 3 Receiver operating curve analyses for major







Overall 69 0.87 (0.74-1.00) 0.81 (0.65-0.98) 0.81 (0.70-0.91)
Gender
Male 26 0.88 (0.72-1.00) 0.91 (0.78-1.00) 0.76 (0.58-0.93)
Female 43 0.85 (0.61-1.00) 0.70 (0.37-1.00) 0.84 (0.70-0.98)
Race
White 47 0.88 (0.73-1.00) 0.87 (0.75-0.99) 0.85 (0.74-0.95)
Non-white‡ 22 0.93 0.31 0.90
Age
< 80 years 38 0.92 (0.81-1.00) 0.81 (0.54-1.00) 0.82 (0.68-0.96)
≥80 years 31 0.80 (0.52-1.00) 0.83 (0.64-1.00) 0.80 (0.62-0.98)
Comorbidities
< 3 41 0.93 (0.82-1.00) 0.92 (0.85-1.00) 0.79 (0.55-1.00)
≥3 28 0.80 (0.57-1.00) 0.71 (0.43-0.99) 0.82 (0.67-0.97)
* N is for PHQ-9 and PHQ-2; GDS is missing for one participant.
† AUC = area under the receiver operating characteristic curve. Values range
from ≤0.5 (no discriminatory ability) to 1.0 (perfect discrimination – in this
case, of depressed from non-depressed).
‡ CI = confidence interval.
§ Only one of the 22 non-white participants had a positive SCID, and
therefore no confidence interval could be calculated.
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instruments. The low study participation may have
affected the prevalence of depression in our study sam-
ple, as one could imagine that those with depression
might be either more or less likely to agree to partici-
pate in a study of depression screening. Lastly, the valid-
ity of the depression instruments for identifying
depression in persons with dementia or those who are
non-English speaking could not be ascertained.
These limitations notwithstanding, this study has several
strengths. First, our study was conducted with a diverse
elderly sample, and we were able to describe the extent
and nature of chronic medical conditions of study partici-
pants. Secondly, the depression screening instruments
were mostly self-administered, with assistance as needed
from the research assistant, while the SCID was conducted
by the study psychiatrist/study nurse practitioner, thus
minimizing the likelihood of agreement of the screening
instruments with the criterion standard. Thirdly, the psy-
chiatrist and nurse practitioner who administered the
SCID were blinded to the results of the depression screen-
ing instruments and to any treatment that the study parti-
cipant may have already been receiving for depression.
Conclusions
In balance, these data suggest that the PHQ-9 performs
comparably to the 15-item GDS when used as a screening
Table 4 Sensitivity and specificity of each screening instrument using a broadened definition of depression*




+ Likelihood Ratio - Likelihood Ratio
PHQ-9 Cutpoint
≥6 77 69 2.5 0.34
(56-90) (63-74)
≥7 77 77 3.3 0.31
(56-90) (70-81)
≥8 77 83 4.4 0.28
(57-89) (76-87)
≥9 71 87 5.2 0.34
(51-85) (80-91)
≥10 59 89 5.1 0.47
(40-74) (82-93)
PHQ-2 Cutpoint
≥1 82 67 2.5 0.26
(62-94) (61-71)
≥2 71 73 2.6 0.40
(50-86) (66-78)
≥3 53 90 5.5 0.52
(35-67) (85-95)
≥4 35 98 18.4 0.66
(21-40) (94-100)
≥5 18 98 9.2 0.84
(7-22) (95-100)
15-item GDS Cutpoint
≥4 94 4 0.98 1.63
(85-99) (1-5)
≥5 88 14 1.0 0.93
(71-96) (8-16)
≥6 81 62 2.1 0.30
(60-93) (55-65)
≥7 56 79 2.7 0.55
(36-74) (73-84)
≥8 31 90 3.3 0.76
(16-46) (86-95)
* Bolded cutpoints indicate the optimum balance between sensitivity and specificity.
‡ CI = confidence interval.
Phelan et al. BMC Family Practice 2010, 11:63
http://www.biomedcentral.com/1471-2296/11/63
Page 7 of 9
instrument for detection of depression among elderly per-
sons in primary care settings. Because of its brevity and its
utility in making specific, DSM-IV based, depression diag-
noses, the PHQ-9 represents a reasonable alternative to
the GDS, particularly in situations where referral to a
mental health provider for definitive diagnostic evaluation
is neither an option nor desired by the patient.
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